Arizona State Retirement System’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-1,835
Closed -$50.7K – 2159
2024
Q3
$50.7K Buy
1,835
+57
+3% +$1.68K ﹤0.01% 2149
2024
Q2
$51.6K Buy
1,778
+47
+3% +$2.24K ﹤0.01% 2097
2024
Q1
$77.2K Sell
1,731
-23
-1% -$985 ﹤0.01% 2099
2023
Q4
$68.1K Sell
1,754
-23
-1% -$828 ﹤0.01% 2126
2023
Q3
$52.2K Buy
1,777
+24
+1% +$1.14K ﹤0.01% 2142
2023
Q2
$111K Buy
+1,753
New +$97K ﹤0.01% 2103

Other funds holding LYEL

Arizona State Retirement System's LYEL Position: Q4 2024 in Review

Arizona State Retirement System sold out of Lyell Immunopharma (LYEL) in Q4 2024, closing a stake of 1,835 shares — an estimated $50.7K sold.

Arizona State Retirement System first reported a position in LYEL in Q2 2023 and held it in 6 quarters. The position peaked at $111K in Q2 2023. 105 funds tracked by Wall St. Rank hold LYEL as of Q4 2024.

  • Arizona State Retirement System reported no remaining Lyell Immunopharma position as of Q4 2024 after selling out during the quarter.
  • Arizona State Retirement System sold 1,835 Lyell Immunopharma shares in Q4 2024, an estimated $50.7K.
  • Arizona State Retirement System first reported a position in Lyell Immunopharma in Q2 2023 and held it in 6 quarters.
  • Arizona State Retirement System's Lyell Immunopharma position peaked at $111K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q4 2024.

Based on Arizona State Retirement System's 13F filing for Q4 2024, filed 6 Feb 2025.